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1. Introduction
Reproductive health is a state 
of complete physical, mental and 
social well-being, and not just the 
absence of diseases or ailments in 
all matters relating to the repro-
ductive system and its functions 
and processes (United Nations, 
1995). The concept of “repro-
ductive health” includes sexual 
health - a condition that allows a 
person to fully experience sexual 
desire and realize it, while receiv-
ing satisfaction. Sexual dishar-
mony increases the risk of gyne-
cological diseases by 2–3 times, 
being one of the main pathoge-
netic links in the development 
of chronic inflammatory diseas-
es of the female genital organs, 
infertility, chronic pelvic pain, 
tumors, pathological menopause 
and other disorders [1].
According to the Princeton 
Consensus [2], female sexual dys-
function can be a sign of andro-
gen deficiency (AD) in women of 
reproductive age, which necessi-
tates the inclusion of appropriate 
therapy in fertility rehabilitation 
protocols for patients with bio-
chemically confirmed AD.
Hormonal changes inevita-
bly affect the physiological regu-
lation of metabolic processes in 
a woman’s body, which, first, is 
manifested by changes in sexual 
behavior, menstrual irregularities 
and decreased fertility. A woman’s 
menstrual cycle brings together 
processes of changes in the activ-
ity of tropic brain structures that 
control the ratio of gonadotropins 
and sex hormones, egg matura-
tion and ovulation, and periodic 
preparation of the endometrium 
for embryo implantation [3]. The 
category of patients with ovarian 
dysfunction (OD) is not the same 
in composition and is divided into 
several groups depending on the 
etiology of the disease. Among 
the causes of ovarian dysfunc-
tion in women of reproductive 
age are the following: weight loss 
for weight loss, increased physi-
cal activity, stress, etc. [4]. More-
over, in women with an already 
formed menstrual cycle, more 
often than not classical (psycho-
genic) amenorrhea is formed, but 
ovarian dysfunction, which is 
based on impaired folliculogene-
sis, ovulation, and functioning of 
the corpus luteum. The unifying 
for these conditions is absolute 
or relative progesterone deficien-
cy and the resulting violations 
of the structural and receptive 
potential of the endometrium and 
mucous membranes of the genital 
tract of women, which leads to 
either acyclic uterine bleeding, or 
oligo-opsomenorrhea, sexual dys-
function [5].
Studying the restoration of 
hormonal support of the repro-
ductive system of women of repro-
ductive age with sexual dysfunc-
tion, we noted that even after 6 
months of normal menstruation, 
biochemically in these women, 
various indicators of LH and FSH 
secretion were observed in rela-
tion to healthy women without 
sexual dysfunction. Some showed 
low (within the limits of reference 
norms) LH indices, while on the 
contrary, there was a clear ten-
dency towards an increase in FSH 
and LH.
In women with high FSH 
and LH, a history of nonspecif-
ic inflammatory diseases of the 
appendages and external-inter-
nal endometriosis were observed 
more often.
Many authors point to the 
importance of the autoimmune 
process in the development of a 
decrease in tolerance to their tis-
sue antigens due to depletion of 
regulatory T-cells and the activa-
tion of autoreactive T-cells as a 
result of molecular mimicry, lead-
ing to the production of antibod-
ies to their own organs or body 
tissues. Induction of a persistent 
T-cell response against intrinsic 
antigens leads to tissue destruc-
tion and repeated stimulation of 
the B-cell response [6]. When an-
alyzing the biopsy material of the 
ovaries (taken during diagnostic 
laparoscopy in women with OD 
and infertility in chronic lympho-
cytic thyroiditis), we noted the 
presence of lymphoid infiltration, 
autoantibodies and complement 
on growing follicles, with intact 
primordial and primary follicles, 
which explains the possibility of 
prolonged existence in some pa-
tients with autoimmune oophor-
itis lack of development of hyper-
gonadotropic ovarian failure. 
The authors [7] report that 
with hypofunction of the ovaries 
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of autoimmune genesis, an increase in inhibin B production 
occurs, in contrast to ovarian insufficiency of another etiol-
ogy, which is due to selective damage to theca interna cells, 
while granulosa cells synthesizing inhibin B remain intact [8]. 
Ovarian failure can also develop due to the presence of chronic 
inflammatory and infectious diseases.
A study of the somatic history of patients with OD and 
sexual dysfunction revealed that women with low LH had auto-
immune diseases: autoimmune thyroiditis, systemic lupus ery-
thematosus, osteoarthritis, etc., which makes us think about the 
multifactorial nature of the problem in this category of patients. 
Aim of the research. The study of the value of inhibin B as a 
prognostic marker of fertility recovery in women with androgen 
deficiency and sexual dysfunction.
2. Materials and methods.
The study was conducted at the Ukrainian Scientific and 
Practical Center for Endocrine Surgery, Transplantation of 
Endocrine Organs and Tissues of the Ministry of Health of 
Ukraine during January-August 2019. The study was conducted 
after the approval of the Ethics Commission of the National 
Medical Academy of Postgraduate Education and in accordance 
with the Code of Ethics of the World Medical Association after 
obtaining information consent from patients.
The study design included 77 women of reproductive age 
of the main group with sexual dysfunction and androgen de-
ficiency: 45 women with sexual dysfunction and the presence 
of thyroperoxidase Ak (I-a group), I-b group of 32 women with 
sexual dysfunction without antibodies to any organism tissues. 
Control group - 31 healthy women of reproductive age.
Diagnostic laparoscopy was performed on an OLYMPUS 
apparatus according to a standard technique according to Clif-
ford R. Wiliss.
Hormone testing was performed using a Johnson & Johnson 
Vitros automated system. Blood samples for the study were taken 
in the morning (8-11) on an empty stomach with venipuncture of 
the ulnar vein. In the control group, the study of hormonal indi-
cators was carried out in the 1st (follicular) phase of the menstrual 
cycle. Ultrasound investigation was performed on an Aloka Hita-
chi apparatus (Japan) with a sensor frequency of 7 MHz.
Sexual dysfunction was determined by the Skindex-16V 
questionnaire, which allows you to consider the state of the 
emotional background, the quality of the sexual life of women 
with vaginal dysfunction. The diagnosis of the examined “Vi-
olation of female sexual desire / arousal” was done according 
to the classification DSM-5. Clinical manifestation of sexual 
dysfunction was> 6 months.
Statistical processing of the results was carried out using the 
statistical program Statistica 8.0 for Windows 7.0 using the meth-
ods of variation statistics for nonparametric data. The results are 
presented as median (Me) and interquartile range [Q25; Q75]. 
For the correlation analysis, the Spearman method was used. To 
determine the reliability in independent groups, the Mann-Whit-
ney U-test was used. The critical level of significance for statistical 
testing of hypotheses in this study was taken to be 0.05.
3. Results
The average age of the examined main group was 32.3± 
±1.7 years, in the control group – 33.9±1.6 years. The average age 
of menarche for women of both groups was 13–14 years (in the 
main 13.3±0.34, in the control – 13.0±0.23 (p>0.05).
The menstrual cycle in patients of the main group was anovu-
latory. Under ultrasound, the endometrium did not correspond to 
the phases of the cycle, cystic ovarian degeneration was detected.
A study of the hormonal background showed a pronounced, 
statistically significant in compare to healthy women decrease 
in the concentrations of not only estradiol (39 [30; 55] and 
150 [116; 218] pmol/L, respectively, p<0.001), but also of andro-
gen: total testosterone (0.1 [0.1; 0.2] and 1.05 [0.8; 1.4] nmol/l, 
p<0.001), free testosterone (1.4 [0.6; 2.0] and 10 [7.0; 16.0] pmol/l, 
p<0.001), as well as dehydroepiandrosterone sulfate (DHEA-S) – 
128.3 [73.3; 850] and 559 [403; 663] nmol/L, p<0.001. FSH in the 
I-a group was 5.3±1.12 U/L, LH 3.2±0.98 U/L, in the I-b group 
it was 11.3±3.12 U/L, LH 8.2±1.7 U/L, in the control 8.3±1.4 U/L, 
LH 7.2±1.2 U/L. The Inhibin B index in the I-a group at 2– 
5 menstrual cycle day: 39±1.23 pg/ml [31; 67] and 115±4.87 
[74; 218] pgr/ml (at a reference rate of 2.6–273 pg/ml). Concen-
trations of sex steroids directly and statistically significantly 
correlated in group I-a with concentrations of gonadotropins 
(luteinizing hormone (LH) and estradiol r=0.67; follicle-stim-
ulating hormone (FSH) and estradiol r=0.64; LH and total 
testosterone r=0.47; FSH and total testosterone r=0.42; for all 
p<0.001). LH and DHEA-S r=0.33 (p=0.02), FSH and DHEA-S 
r=0.27 (p=0.03). In group I-b, LH correlation and total testoster-
one r=0.58 p<0.001) were noted.
Diagnostic laparoscopy with ovarian biopsy was performed 
in 12 women of group I-a and 23 of group I-b. At the same 
time, the presence of lymphoid infiltration, autoantibodies and 
complement on growing follicles was established, with primor-
dial and primary follicles intact. Tissue fibrosis, the presence of 
activated B and T lymphocytes: CD8+, CD4+, natural killer cells 
(NK), polyclonal plasmocytes, macrophages of primordial and 
primary follicles were characteristic for group I-b.
4. Discussion
The revealed biochemical changes in women with sexual 
dysfunction and androgen deficiency made it possible to clarify 
the cause of hormonal changes in the reproductive background 
in the examined patients. As we see in group I-b, the inhibin B 
index is closer to the lower limit of the norm – which may indicate 
ovarian hypofunction of autoimmune genesis, which is caused 
by selective damage to theca interna cells, while granulosa cells 
synthesizing inhibin B remain intact. Other researchers came to 
the same conclusions [9]. Thus, according to the obtained data, 
the level of inhibin B can be a marker of the depth of damage to 
the follicular reserve in women with sexual dysfunction.
The results of histological studies confirm the difference in 
the etiology of androgen deficiency in women with sexual dys-
function and androgen deficiency. These results are consistent 
with the data of researchers [10] that ovarian hypofunction of 
autoimmune origin is caused by selective damage to theca interna 
cells, while granulosa cells synthesizing inhibin B remain intact.
The knowledge of the revealed changes shows the ways to 
eliminate ovarian dysfunction in women of reproductive age with 
AD and female sexual dysfunction. The level of inhibin B can serve 
as an early marker of autoimmune ovarian damage in women of 
reproductive age with female sexual dysfunction. However, in com-
parison with a large database of studies of reproductive dysfunction 
and premature ovarian exhaustion syndrome, there are few studies 
of ovarian dysfunction in women with androgen deficiency and 
sexual dysfunctions in the literature. This makes it important and 
advisable to continue studying the markers of androgen deficiency 
in women with sexual dysfunctions and to develop methods for 
correcting androgen deficiency in women of reproductive age, 
taking into account the pathogenesis of the disease.
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